GHK-Cu (Glycyl-L-histidyl-L-lysine copper complex) is a naturally occurring tripeptide–copper(II) complex found at high concentrations in human plasma during youth, declining ~60% between age 20 and 60. It acts as a master regulator of gene expression, modulating over 4,000 human genes — effects on collagen synthesis, antioxidant defence, angiogenesis, and anti-inflammatory signalling. Our 50mg vial is one of the largest research doses in Canada.
- Broad gene-regulatory activity — modulates 4,000+ genes including collagen I, elastin, fibronectin, VEGF, and superoxide dismutase.
- Collagen and elastin synthesis — stimulates dermal fibroblast production of structural matrix proteins.
- Anti-inflammatory pathway suppression — inhibits NF-κB and pro-inflammatory cytokines (TNF-α, IL-6, IL-1β).
- Angiogenesis and wound repair — promotes VEGF-mediated blood vessel outgrowth and nerve regeneration.
- 50mg large-format vial — rare high-dose format among Canadian research peptide suppliers.
⚠️ For research use only. Not for human or animal consumption. Store at −20°C. Reconstitute with Bacteriostatic Water.






Reviews
There are no reviews yet.